Table 2.

Bivariate and multivariate logistic regression for factors associated with inappropriate PI prescription during rifampicin-based TB treatment

	Crude Odds ratio (95% CI)	P value	Adjusted Odds ratio (95% CI)	P value
Cadre of prescribing clinician
Clinical officer	1		1
Doctor	0.22 (0.13–0.36)	< 0.001	0.26 (0.15–0 .46)	< 0.001
Nurse	0.27 (0.15–0.47)	< 0.001	0.35 (0.18–0 .71)	0.003
Clinic level
KCCA	1		1
RRH	2.08 (1.26–4.18)	0.004	1.10 (0.60–2.03)	0.760
Age (years)
< 25	1		1
25–34	0.87 (0.47–1.59)	0.657	0.86 (0.42–1.76)	0.679
35–44	1.04 (0.56–1.91)	0.889	0.97 (0.47–2.01)	0.939
45–54	1.48 (0.69–3.16)	0.310	1.24 (0.52–2.96)	0.629
55–64	0.29 (0.11–0.76)	0.012	0.33 (0.11–1.02)	0.053
Weight (kg)
< 33	1		1
33–39	1.41 (0.47–4.21)	0.534	1.10 (0.33–3.70)	0.878
40–54	2.14 (0.89–5.10)	0.086	1.95 (0.71–5.38)	0.197
55–70	1.88 (0.77–4.61)	0.164	1.78 (0.59–5.32)	0.305
> 70	0.62 (0.20–1.90)	0.402	0.49 (0.12–1.94)	0.310
Duration on PI before TB treatment
PI and TB treatment started the same day	1		1
< 1 year	1.35 (0.81–2.27)	0.245	1.01 (0.58–1.77)	0.975
1 year–≤ 2 years	2.41 (1.21–4.80)	0.012	1.45 (0.69–3.05)	0.322
> 2 years	2.96 (1.57–5.55)	0.001	1.56 (0.77–3.16)	0.216

KCCA Kampala City Council Authority, RRH Regional Referral Hospital, inappropriate PI prescription  prescription of LPV/r 400/100 mg BID or a prescription of ATV/r